Tiszalök, Hungary

Erika Nagy

This inventor holds 1 USPTO granted patent. Top assignee: Alkaloida Vegyeszeti Gyar. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Erika Nagy

Introduction

Erika Nagy is a notable inventor based in Tiszalök, Hungary. She has made significant contributions to the field of chemistry, particularly in the development of anti-hypertensive medications. Her work exemplifies the intersection of innovation and practical application in the pharmaceutical industry.

Latest Patents

Erika Nagy holds a patent for a process titled "Process for the preparation of anti-hypertensive benzopyran." This patent describes a method for synthesizing (±)-6-cyano-3,4-dihydro-2,2-dimethyl-trans-4-(2-oxo-1-pyrrolidino)-2H-1-benzopyran-3-ol. The process involves reacting 4-cyanophenol with isoprene, followed by bromination and dehydrobromination steps, ultimately leading to the desired compound.

Career Highlights

Erika Nagy is associated with Alkaloida Vegyeszeti Gyar, a company known for its contributions to the pharmaceutical sector. Her work at this organization has been pivotal in advancing the development of new therapeutic agents. With her expertise, she has been able to navigate complex chemical processes to create effective solutions for hypertension.

Collaborations

Erika has collaborated with esteemed colleagues such as Peter Sebok and Tibor Timar. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the field.

Conclusion

Erika Nagy’s contributions to the field of chemistry and her innovative patent for anti-hypertensive benzopyran highlight her role as a significant inventor. Her work continues to impact the pharmaceutical industry positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…